亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台，协助业界发掘知识产权贸易商机，并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权，或是制造商需要购买技术以提高操作效能，又或是知识产权配套服务供应商，你将会从本网站发掘到有用的知识产权贸易资讯。
Potent small molecule xanthine oxidase inhibitors for the treatment of gout/hyperuricemia
技术应用
- Compared to currently approved drugs, DHNB is a safe, effective, and stable XO inhibitor with similar potency as current therapies used to reduce uric acid production, but with much lower toxicity. Therefore, it is suitable for long term use to treat and/or prevent hyperuricemia and gout.- DHNB binds to the XO enzyme with high specificity. It may be used alone or in combination with traditional drugs to enhance efficacy and prevent drug resistance.- DHNB, but not other XO inhibitors, has beneficial antioxidant properties.- BCM researchers have developed novel small molecule XO inhibitors based on the chemical structure of DHNB.
详细技术说明
None
国家/地区
美国
欲了解更多信息，请点击 这里
